PT Siloam International Hospitals Tbk (FRA:2LS) Growth Rank: 10 (As of Jul. 18, 2026) — 11% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:2LS PT Siloam International Hospitals Tbk FRA:2LS
93 GF Score
Price €0.10
GF Value €0.12
! 2 Warning Signs
View Full Analysis

What is PT Siloam International Hospitals Tbk Growth Rank?

PT Siloam International Hospitals Tbk FRA:2LS 93 Growth Rank is 10 as of Jul. 18, 2026, which is 11% above its 10-year median of 9.00. GuruFocus rates FRA:2LS with a GF Score™ of 93/100 and a GF Value™ of €0.12. The stock has 2 warning signs investors should review.

PT Siloam International Hospitals Tbk has the Growth Rank of 10.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

PT Siloam International Hospitals Tbk Growth Rank Related Terms

FRA:2LS vs HCA, THC, DVA: Growth Rank Comparison

For the Medical Care Facilities subindustry, PT Siloam International Hospitals Tbk's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Siloam International Hospitals Tbk Growth Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PT Siloam International Hospitals Tbk's Growth Rank distribution charts can be found below:

* The bar in red indicates where PT Siloam International Hospitals Tbk's Growth Rank falls into.


FRA:2LS
93GF Score
PT Siloam International Hospitals Tbk FRA:2LS
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 10 mean?
PT Siloam International Hospitals Tbk (FRA:2LS) has a Growth Rank of 10 as of Jul. 18, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on PT Siloam International Hospitals Tbk and its competitors. This is 11% above median its historical median of 9.00. Over the past decade, PT Siloam International Hospitals Tbk's Growth Rank has ranged from 3.00 to 10.00.
Is PT Siloam International Hospitals Tbk's Growth Rank too high?
PT Siloam International Hospitals Tbk's current Growth Rank of 10 is 11% above median its 10-year median of 9.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 10.00. Overall, PT Siloam International Hospitals Tbk has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does PT Siloam International Hospitals Tbk's Growth Rank compare to HCA and THC?
PT Siloam International Hospitals Tbk's Growth Rank of 10 can be compared against companies in the Healthcare Providers & Services industry. Historically, PT Siloam International Hospitals Tbk's own Growth Rank has ranged from 3.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Healthcare Providers & Services company?
A good Growth Rank depends on the Healthcare Providers & Services industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on PT Siloam International Hospitals Tbk and its competitors. PT Siloam International Hospitals Tbk's current Growth Rank is 10, which is 11% above median its own 10-year median of 9.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Siloam International Hospitals Tbk stock overvalued right now?
PT Siloam International Hospitals Tbk (FRA:2LS) has a current Growth Rank of 10. The stock's GF Value™ is €0.12, compared to a current price of €0.10 — trading 19.6% below its estimated fair value. The current Growth Rank is 10, which is 11% above median its 10-year median of 9.00. PT Siloam International Hospitals Tbk's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For PT Siloam International Hospitals Tbk (FRA:2LS), the current Growth Rank is 10 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Siloam International Hospitals Tbk (FRA:2LS) Overvalued in 2026?

Based on GuruFocus' analysis, PT Siloam International Hospitals Tbk stock appears to be undervalued. The current stock price of €0.10 is trading 19.6% below its estimated GF Value™ of €0.12.

Key valuation signals for FRA:2LS:

  • Growth Rank: 10 (11% above median its 10-year median of 9.00)
  • GF Value™: €0.12 vs. price of €0.10 (19.6% below fair value)
  • GF Score™: 93/100 with 2 warning signs

No single metric tells the full story. See the FRA:2LS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Siloam International Hospitals Tbk Business Description

Other Exchanges SILO:Indonesia
Address No. 15, Jalan Boulevard Sudirman, Floor 32, Gedung Fakultas Kedokteran Universitas Pelita Harapan, Lippo Village, Tangerang, IDN, 15810
PT Siloam International Hospitals Tbk operates a network of hospitals in Indonesia. Its hospitals are located in the Greater Jakarta area and across Java, Sumatra, Kalimantan, Sulawesi, Bali, Nusa Tenggara, Ambon, and other areas across Indonesia, along with several Siloam Clinics. The company offers an integrated, one-stop care ecosystem designed to provide comprehensive healthcare services, spanning examination, diagnosis, clinical management, rehabilitation, and health education. Additionally, it offers special clinical services in the following segments, including neurosciences, neurology, digestive, cardiac, orthopedic, etc., by running the Center of Excellence and specialty centers. The company generates the majority of its revenue by offering hospitalization and outpatient services.
93GF Score

Get the complete analysis for FRA:2LS

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price
€0.12
GF Value